In the present study, we tried to clarify the possible involvement of DCK in sensitivities to Ara‐C and clofarabine using a wide variety of B‐cell precursor ALL (BCP‐ALL) cell lines. The gene discussed is DCK; the disease is acute lymphoblastic leukemia.